Ameriprise Financial Inc Ocular Therapeutix, Inc Transaction History

Ameriprise Financial Inc

  • $375 Billion
  • Q4 2024

A detailed history of Ameriprise Financial Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 89,772 shares of OCUL stock, worth $662,517. This represents 0.0% of its overall portfolio holdings.

Number of Shares
89,772
Previous 49,072 82.94%
Holding current value
$662,517
Previous $426,000 79.81%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$8.33 - $11.47 $339,031 - $466,829
40,700 Added 82.94%
89,772 $766,000
Q3 2024

Nov 14, 2024
BUY
$6.45 - $9.23 $80,812 - $115,642
12,529 Added 34.29%
49,072 $426,000
Q2 2024

Aug 14, 2024
BUY
$4.2 - $8.69 $20,189 - $41,772
4,807 Added 15.15%
36,543 $249,000
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $10,533 - $29,904
2,736 Added 9.43%
31,736 $288,000
Q4 2023

Feb 14, 2024
SELL
$2.08 - $4.52 $7,508 - $16,317
-3,610 Reduced 11.07%
29,000 $129,000
Q3 2023

Nov 14, 2023
BUY
$3.14 - $5.04 $8,179 - $13,129
2,605 Added 8.68%
32,610 $102,000
Q2 2023

Aug 14, 2023
SELL
$4.6 - $7.64 $24,908 - $41,370
-5,415 Reduced 15.29%
30,005 $154,000
Q1 2023

May 15, 2023
BUY
$2.79 - $6.27 $14,005 - $31,475
5,020 Added 16.51%
35,420 $186,000
Q4 2022

Feb 14, 2023
SELL
$2.61 - $4.41 $28,861 - $48,765
-11,058 Reduced 26.67%
30,400 $85,000
Q3 2022

Nov 14, 2022
BUY
$4.09 - $6.5 $2,454 - $3,900
600 Added 1.47%
41,458 $172,000
Q2 2022

Aug 15, 2022
BUY
$3.01 - $5.22 $66,189 - $114,787
21,990 Added 116.55%
40,858 $164,000
Q1 2022

May 16, 2022
SELL
$4.83 - $7.35 $16,180 - $24,622
-3,350 Reduced 15.08%
18,868 $93,000
Q4 2021

Feb 14, 2022
BUY
$6.16 - $12.07 $136,862 - $268,171
22,218 New
22,218 $155,000
Q3 2021

Nov 15, 2021
SELL
$9.7 - $14.34 $110,706 - $163,662
-11,413 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.43 - $19.16 $1,651 - $2,356
123 Added 1.09%
11,413 $162,000
Q1 2021

May 17, 2021
SELL
$15.82 - $22.11 $22,939 - $32,059
-1,450 Reduced 11.38%
11,290 $186,000
Q4 2020

Feb 12, 2021
SELL
$7.91 - $22.95 $14,475 - $41,998
-1,830 Reduced 12.56%
12,740 $264,000
Q3 2020

Nov 16, 2020
BUY
$7.36 - $9.87 $3,680 - $4,935
500 Added 3.55%
14,570 $111,000
Q2 2020

Aug 14, 2020
SELL
$4.67 - $8.95 $25,769 - $49,386
-5,518 Reduced 28.17%
14,070 $117,000
Q1 2020

May 15, 2020
BUY
$3.95 - $7.4 $33,902 - $63,514
8,583 Added 77.99%
19,588 $97,000
Q4 2019

Feb 14, 2020
BUY
$2.57 - $4.73 $12 - $23
5 Added 0.05%
11,005 $43,000
Q3 2019

Nov 14, 2019
BUY
$3.04 - $5.32 $33,440 - $58,520
11,000 New
11,000 $33,000

Others Institutions Holding OCUL

# of Institutions
190
Shares Held
132M
Call Options Held
374K
Put Options Held
179K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $568M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email